Maria Sanchez immigrated to the Chicago area from Mexico about 30 years ago. Now 87, she’s still living in the U.S. without authorization. Like many longtime immigrants, she has worked — and paid taxes, including Medicare taxes — all that time. But Sanchez never had health insurance, and when she turned 65, she couldn’t enroll…
KFF Health News chief Washington correspondent Julie Rovner discussed the Senate hearing of former Centers for Disease Control and Prevention director Susan Monarez on WBUR’s “Here & Now” on Sept. 17. Rovner also delved into the “Make America Healthy Again” report on children’s health on WNYC’s “The Brian Lehrer Show” on Sept. 16 and on…
OTTUMWA, Iowa — Leisa and Kent Walker recently received a disturbing notice: The private company managing their son’s Medicaid coverage intends to cut nearly 40% of what it spends for caregivers who help him live at home instead of in a nursing home. Sam Walker, 35, has severe autism and other disabilities. He is deaf…
AMIA notes that health system’s chief data scientist is a longtime leader in using all types of data to drive better decision making and science
Precigen’s Papzimeos is the first FDA-approved drug for the rare disease recurrent respiratory papillomatosis, or RRP. While this immunotherapy carries blockbuster expectations, Precigen’s financial reports indicate budgetary challenges. The post First Therapy for Rare Tumor Is a Blockbuster Prospect, But Does Precigen Have the Cash to Make It Happen? appeared first on MedCity News.
Many of today’s systems weren’t built for speed, supervision, or scale, and they can’t support the level of intelligence or flexibility that modern care delivery demands. The solution isn’t to retreat from APPs. It’s to invest in models that make their work safe, effective, and scalable. The post The Future of Specialty Care: APPs, MDs,…
‘The basics that we learned about in security are 10 times more important in an agentic world,’ Anthropic’s Rob Bair tells CHAI’s AI Cybersecurity Work Group
By KIM BELLARD Over the years, one area of tech/health tech I have avoided writing about are brain-computer interfaces (B.C.I.). In part, it was because I thought they were kind of creepy, and, in larger part, because I was increasing finding Elon Musk, whose Neuralink is one of the leaders in the field, even more…
For two decades, Washington, D.C., pediatrician Lanre Falusi has counseled parents about vaccine safety, side effects, and timing. But this year, she said, the conversations have changed. “For the first time, I’m having parents of newborns ask me if their baby will still be able to get vaccines,” Falusi said. Throughout the country, pediatricians say…
Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna’s vaccine candidate for avian influenza is on track for Phase 3 testing. But the Department of Health and Human Services has canceled a $590 million contract to support Moderna’s pivotal trial. The post Bird Flu Threat Still…